These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 31164507)
1. [A Nutritional Supplement with a High Blend Ratio of ω-3 Fatty Acids(Prosure®) Reduces Severe Oral Mucositis and Body Weight Loss for Head and Neck Cancer Patients Treated with Chemoradiotherapy]. Mizumachi T; Kano S; Homma A; Akazawa M; Hasegawa C; Shiroishi Y; Okamoto C; Kumagai S; Nishimura M; Takasaki H; Takeda H; Yasuda K; Minatogawa H; Dekura Y; Onimaru R; Shirato H; Fukuda S Gan To Kagaku Ryoho; 2019 Apr; 46(4):685-689. PubMed ID: 31164507 [TBL] [Abstract][Full Text] [Related]
2. Hangeshashinto improves the completion rate of chemoradiotherapy and the nutritional status in patients with head and neck cancer. Hatakeyama H; Takahashi H; Oridate N; Kuramoto R; Fujiwara K; Homma A; Takeda H; Fukuda S ORL J Otorhinolaryngol Relat Spec; 2015; 77(2):100-8. PubMed ID: 25896416 [TBL] [Abstract][Full Text] [Related]
3. Prospective randomized investigation implementing immunonutritional therapy using a nutritional supplement with a high blend ratio of ω-3 fatty acids during the perioperative period for head and neck carcinomas. Hanai N; Terada H; Hirakawa H; Suzuki H; Nishikawa D; Beppu S; Hasegawa Y Jpn J Clin Oncol; 2018 Apr; 48(4):356-361. PubMed ID: 29420749 [TBL] [Abstract][Full Text] [Related]
4. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study. Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585 [TBL] [Abstract][Full Text] [Related]
5. [The timing of the appearance of oral mucositis induced by concurrent chemoradiotherapy with S-1 for head and neck cancer]. Yonekita H; Takase H; Ogata K; Futagami K; Nomoto S; Yoshimitsu K; Nakagawa T; Tokunaga S Gan To Kagaku Ryoho; 2014 Dec; 41(13):2571-5. PubMed ID: 25596050 [TBL] [Abstract][Full Text] [Related]
6. Double-blind, randomized pilot study of bioadhesive chlorhexidine gel in the prevention and treatment of mucositis induced by chemoradiotherapy of head and neck cancer. Diaz-Sanchez RM; Pachón-Ibáñez J; Marín-Conde F; Rodríguez-Caballero Á; Gutierrez-Perez JL; Torres-Lagares D Med Oral Patol Oral Cir Bucal; 2015 May; 20(3):e378-85. PubMed ID: 25662553 [TBL] [Abstract][Full Text] [Related]
7. [Investigation of how to prevent mucositis induced by chemoradiotherapy]. Tosaka C; Tajima H; Inoue T; Moya M; Kobayashi M; Miura K; Tada Y; Masubuchi T; Hushimi C; Kamata S Gan To Kagaku Ryoho; 2011 Oct; 38(10):1647-51. PubMed ID: 21996960 [TBL] [Abstract][Full Text] [Related]
8. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer. Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692 [TBL] [Abstract][Full Text] [Related]
9. A Randomized, Placebo-Controlled Study to Evaluate the Effect of Bio-Enhanced Turmeric Formulation on Radiation-Induced Oral Mucositis. Soni TP; Gupta AK; Sharma LM; Singhal H; Sharma S; Gothwal RS ORL J Otorhinolaryngol Relat Spec; 2022; 84(2):103-113. PubMed ID: 34161952 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study. Yokota T; Ogawa T; Takahashi S; Okami K; Fujii T; Tanaka K; Iwae S; Ota I; Ueda T; Monden N; Matsuura K; Kojima H; Ueda S; Sasaki K; Fujimoto Y; Hasegawa Y; Beppu T; Nishimori H; Hirano S; Naka Y; Matsushima Y; Fujii M; Tahara M BMC Cancer; 2017 May; 17(1):314. PubMed ID: 28476132 [TBL] [Abstract][Full Text] [Related]
11. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer. Yen SH; Wang LW; Lin YH; Jen YM; Chung YL Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of polyacrylate silver salt/polyvinylpyrrolidone-based liquid oral gel in management of concurrence chemoradiotherapy-induced oral mucositis. Chin HL; Chung KP; Liu HC; Chen RS; Chang HH; Chen MH J Formos Med Assoc; 2023 Aug; 122(8):723-730. PubMed ID: 36623972 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of elemental diet on prevention for chemoradiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma. Harada K; Ferdous T; Horinaga D; Uchida K; Mano T; Mishima K; Park S; Hanazawa H; Takahashi S; Okita A; Fukunaga M; Maruta J; Kami N; Shibuya K; Ueyama Y Support Care Cancer; 2016 Feb; 24(2):953-959. PubMed ID: 26248650 [TBL] [Abstract][Full Text] [Related]
14. A traditional Japanese medicine--Hangeshashinto (TJ-14)--alleviates chemoradiation-induced mucositis and improves rates of treatment completion. Yamashita T; Araki K; Tomifuji M; Kamide D; Tanaka Y; Shiotani A Support Care Cancer; 2015 Jan; 23(1):29-35. PubMed ID: 24943276 [TBL] [Abstract][Full Text] [Related]
15. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial. Tsujimoto T; Yamamoto Y; Wasa M; Takenaka Y; Nakahara S; Takagi T; Tsugane M; Hayashi N; Maeda K; Inohara H; Uejima E; Ito T Oncol Rep; 2015 Jan; 33(1):33-9. PubMed ID: 25351453 [TBL] [Abstract][Full Text] [Related]
16. A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer. Yokota T; Hamauchi S; Yoshida Y; Yurikusa T; Suzuki M; Yamashita A; Ogawa H; Onoe T; Mori K; Onitsuka T Support Care Cancer; 2018 Sep; 26(9):3241-3248. PubMed ID: 29627862 [TBL] [Abstract][Full Text] [Related]
17. Effects of early nutritional intervention by a nutritional support team for patients with head and neck cancer undergoing chemoradiotherapy or radiotherapy. Kono M; Wakisaka R; Kumai T; Hayashi R; Komatsuda H; Sato R; Abe Y; Yamaki H; Takahara M; Katada A; Hayashi T; Harabuchi Y Head Neck; 2021 Feb; 43(2):514-519. PubMed ID: 33015926 [TBL] [Abstract][Full Text] [Related]
18. Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy. Bossi P; Bergamini C; Miceli R; Cova A; Orlandi E; Resteghini C; Locati L; Alfieri S; Imbimbo M; Granata R; Mariani L; Iacovelli NA; Huber V; Cavallo A; Licitra L; Rivoltini L Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):959-966. PubMed ID: 27745982 [TBL] [Abstract][Full Text] [Related]
19. Effects of honey on oral mucositis in patients with head and neck cancer: A meta-analysis. Cho HK; Jeong YM; Lee HS; Lee YJ; Hwang SH Laryngoscope; 2015 Sep; 125(9):2085-92. PubMed ID: 25778825 [TBL] [Abstract][Full Text] [Related]
20. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma. Cerchietti LC; Navigante AH; Bonomi MR; Zaderajko MA; Menéndez PR; Pogany CE; Roth BM Cancer; 2002 Nov; 95(10):2230-6. PubMed ID: 12412178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]